IP Verse

University Of Washington Through Its Center For Commercialization competitive analysis

Loading summary...

Latest patents of University Of Washington Through Its Center For Commercialization opposed by its competitors

Explore University Of Washington Through Its Center For Commercialization's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2838548
Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof2
EP2828218
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing3
EP2699593
Nov 4, 2020Beta-2 Microglobulin-Deficient Cells1

Latest PTAB cases involving University Of Washington Through Its Center For Commercialization

Discover the latest PTAB cases involving University Of Washington Through Its Center For Commercialization, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing University Of Washington Through Its Center For Commercialization with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION - 6 - -
JAMES POOLE153 - - -
LEWIS SILKIN2 - - -
MARGARET DIXON59 - - -